TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
OBS! Utsatt för bedrägeri/ Neuroangiognosis NK AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
205
|
234
|
354 |
| Financial expenses |
0
|
8
|
0 |
| Earnings before taxes |
139
|
148
|
261 |
| EBITDA |
111
|
154
|
262 |
| Total assets |
1,641
|
1,470
|
1,437 |
| Current assets |
1,641
|
1,470
|
1,437 |
| Current liabilities |
282
|
204
|
147 |
| Equity capital |
1,276
|
1,188
|
1,211 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
77.8%
|
80.8%
|
84.3% |
| Turnover per employee |
205
|
234
|
354 |
| Profit as a percentage of turnover |
67.8%
|
63.2%
|
73.7% |
| Return on assets (ROA) |
8.5%
|
10.6%
|
18.2% |
| Current ratio |
581.9%
|
720.6%
|
977.6% |
| Return on equity (ROE) |
10.9%
|
12.5%
|
21.6% |
| Change turnover |
-30
|
-91
|
-36 |
| Change turnover % |
-13%
|
-28%
|
-9% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.